Press Releases

and/or
572 News Releases found
Lisa DeAngelis, Bob li, Kenneth Manotti, and Sir Murray Brennan
COVID-19 is continuing to make headlines around the world this year. Yet cancer will kill a larger number of people globally – 10 million every year. Patients with cancer are more vulnerable to contracting COVID-19, and have more than double the death rate from COVID-19 compared to patients without cancer.
MSK Awards & Appointments
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
MSK's David Pfister, Nancy Lee, and Richard Wong
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number one center for ear, nose, and throat care by U.S. News & World Report. MSK has been consistently ranked among the top two cancer centers in the country for over 30 years.
MSK Awards & Appointments
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Crain’s New York Business 2021 Notable in Health Care honorees
Dr. Craig Thompson, Dr. Peter Bach, Dr. Ushma Neill, and Dr. William Rosa were recognized for their professional, civic, and philanthropic achievements.
Participants rode at Cycle for Survival’s first ever socially distant outdoor ride at MetLife Stadium in New Jersey. 
With founding partner Equinox, Cycle for Survival surpasses $285 million raised since 2007; every dollar funds rare cancer research led by Memorial Sloan Kettering Cancer Center.
MSK Awards & Appointments
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
MSK leadership applauding for graduates
For the 15th year, MSK honored the academic achievements of our youngest patients by hosting MSK Kids Convocation - a virtual ceremony to help mark and celebrate the end of their adolescent school years.
Michael Morris, MD
New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).